Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction

In English

Författare

  • George J. Dawson
  • George G. Schlauder
  • Tami J. Pilot-Matias
  • Dwain Thiele
  • Thomas P. Leary
  • Paul Murphy
  • Jon E Rosenblatt
  • John N. Simons
  • Francis E.A. Martinson
  • Robin A. Gutierrez
  • Joseph R. Lentino
  • Constance Pachucki
  • A. Scott Muerhoff
  • Anders Widell
  • Gary Tegtmeier
  • Suresh Desai
  • Isa K. Mushahwar
Visa allt

Summary, in English

Among the three recently described GB viruses (GBV-A, GBV-B, and GBV-C), only GBV-C has been linked to cryptogenic hepatitis in man. Because of the limited utility of currently available research tests to determine antibody response to GBV-C proteins, the prevalence of GBV-C RNA in human sera was studied using reverse transcription-polymerase chain reaction (RT-PCR). The prevalence of GBV-C is higher among volunteer blood donors with elevated serum alanine aminotransferase (ALT) levels (3.9%) than among volunteer blood donors with normal ALT levels (0.8%). Higher rates were also noted among commercial blood donors (12.9%) and intravenous drug users (16.0%). GBV-C was frequently detected in residents of West Africa, where the prevalence was > 10% in most age groups. Approximately 20% of patients diagnosed with either acute or chronic hepatitis C virus (HCV) were found to be positive for GBV-C RNA. In addition, GBV-C RNA sequences were detected in individuals diagnosed with non-A-E hepatitis, with clinical courses ranging from mild disease to fulminant hepatitis. Fourteen of sixteen subjects with or without clinically apparent hepatitis were positive for GBV-C RNA more than 1 year after the initial positive result.

Publiceringsår

1996

Språk

Engelska

Sidor

97-103

Publikation/Tidskrift/Serie

Journal of Medical Virology

Volym

50

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

John Wiley & Sons Inc.

Ämne

  • Microbiology in the medical area

Nyckelord

  • HCV
  • GBV-C
  • hepatitis

Status

Published

Forskningsgrupp

  • Clinical Microbiology, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1096-9071